2 Information about fluocinolone acetonide intravitreal implant
|
Marketing authorisation indication |
Fluocinolone acetonide intravitreal implant (Iluvien, Alimera Sciences) is indicated for 'prevention of relapse in recurrent non-infectious uveitis affecting the posterior segment of the eye'. |
|---|---|
|
Dosage in the marketing authorisation |
Fluocinolone acetonide intravitreal implant is administered through intravitreal injection. Each implant contains 0.19 mg of fluocinolone acetonide and releases fluocinolone acetonide for up to 36 months. |
|
Price |
£5,500 per implant (excluding VAT, British national formulary online [accessed May 2019]). The company has a commercial arrangement. This makes fluocinolone acetonide intravitreal implant available to the NHS with a discount. The size of the discount is commercial in confidence. It is the company's responsibility to let relevant NHS organisations know details of the discount. |